NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC • US6373722023

12.09 USD
+0.01 (+0.08%)
Last: Feb 17, 2026, 11:17 AM
Fundamental Rating

5

Overall NRC gets a fundamental rating of 5 out of 10. We evaluated NRC against 102 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NRC was profitable.
  • In the past year NRC had a positive cash flow from operations.
  • In the past 5 years NRC has always been profitable.
  • NRC had a positive operating cash flow in each of the past 5 years.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • NRC's Return On Assets of 8.60% is amongst the best of the industry. NRC outperforms 91.18% of its industry peers.
  • Looking at the Return On Equity, with a value of 82.92%, NRC belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
  • NRC's Return On Invested Capital of 16.19% is amongst the best of the industry. NRC outperforms 93.14% of its industry peers.
  • NRC had an Average Return On Invested Capital over the past 3 years of 24.89%. This is significantly above the industry average of 8.98%.
  • The 3 year average ROIC (24.89%) for NRC is well above the current ROIC(16.19%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROIC 16.19%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

1.3 Margins

  • NRC's Profit Margin of 8.44% is amongst the best of the industry. NRC outperforms 90.20% of its industry peers.
  • NRC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.44%, NRC belongs to the top of the industry, outperforming 95.10% of the companies in the same industry.
  • NRC's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 61.88%, NRC belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
Industry RankSector Rank
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. Health

2.1 Basic Checks

  • NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for NRC has been reduced compared to 1 year ago.
  • The number of shares outstanding for NRC has been reduced compared to 5 years ago.
  • NRC has a worse debt/assets ratio than last year.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.60 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NRC has a Altman-Z score (2.60) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of NRC is 5.02, which is a neutral value as it means it would take NRC, 5.02 years of fcf income to pay off all of its debts.
  • NRC has a better Debt to FCF ratio (5.02) than 62.75% of its industry peers.
  • NRC has a Debt/Equity ratio of 5.36. This is a high value indicating a heavy dependency on external financing.
  • NRC has a Debt to Equity ratio of 5.36. This is in the lower half of the industry: NRC underperforms 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Altman-Z 2.6
ROIC/WACC2.01
WACC8.04%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that NRC may have some problems paying its short term obligations.
  • NRC's Current ratio of 0.55 is on the low side compared to the rest of the industry. NRC is outperformed by 86.27% of its industry peers.
  • NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NRC has a Quick ratio of 0.55. This is amonst the worse of the industry: NRC underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1

3. Growth

3.1 Past

  • NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.56%.
  • NRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.24% yearly.
  • Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.96% in the last year.
  • NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.67, the valuation of NRC can be described as very reasonable.
  • 93.14% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.19, NRC is valued rather cheaply.
Industry RankSector Rank
PE 9.67
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 68.63% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, NRC is valued a bit cheaper than 71.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.39
EV/EBITDA 11.53
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.99
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • NRC has a Yearly Dividend Yield of 4.99%, which is a nice return.
  • In the last 3 months the price of NRC has falen by -20.68%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.48, NRC pays a better dividend. On top of this NRC pays more dividend than 99.02% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.99%

5.2 History

  • The dividend of NRC has a limited annual growth rate of 2.80%.
  • NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.8%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • NRC pays out 94.64% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of NRC is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP94.64%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (2/17/2026, 11:17:47 AM)

12.09

+0.01 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners49.6%
Inst Owner Change-1.76%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap273.72M
Revenue(TTM)137.39M
Net Income(TTM)11.60M
Analysts45
Price TargetN/A
Short Float %3.05%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 4.99%
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP94.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.67
Fwd PE N/A
P/S 1.99
P/FCF 17.39
P/OCF 10.35
P/B 19.57
P/tB N/A
EV/EBITDA 11.53
EPS(TTM)1.25
EY10.34%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.75%
OCF(TTM)1.17
OCFY9.66%
SpS6.07
BVpS0.62
TBVpS-2.3
PEG (NY)N/A
PEG (5Y)2.99
Graham Number4.17
Profitability
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROCE 22.99%
ROIC 16.19%
ROICexc 16.9%
ROICexgc 56.88%
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
FCFM 11.46%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.43%
ROICexc(5y)39.02%
ROICexgc(3y)111.05%
ROICexgc(5y)N/A
ROCE(3y)35.35%
ROCE(5y)42.3%
ROICexgc growth 3Y-50.84%
ROICexgc growth 5Y-30.78%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.55%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Debt/EBITDA 2.48
Cap/Depr 140.43%
Cap/Sales 7.79%
Interest Coverage 250
Cash Conversion 87.54%
Profit Quality 135.72%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 2.6
F-Score6
WACC8.04%
ROIC/WACC2.01
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)95.08%
Profit Quality(5y)95.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.69%
EBIT growth 3Y-27.99%
EBIT growth 5Y-11.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NRC.


Can you provide the valuation status for NATIONAL RESEARCH CORP?

ChartMill assigns a valuation rating of 5 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?

The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 9.67 and the Price/Book (PB) ratio is 19.57.


Can you provide the financial health for NRC stock?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.